2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Cancer Imaging Techniques
In all stages of cancer treatment, a variety of biomedical imaging techniques are used. Imaging is an important aspect of cancer treatment procedures because it can provide morphological, structural, metabolic, and functional data. Despite breakthroughs in many areas of diagnostic radiology, human cancer detection and imaging remain a concern. Biomedical imaging is becoming increasingly relevant in all stages of cancer management. Clinical decision-making is assisted by integration with other diagnostic technologies such as in vitro tissue and fluid analyses. Early diagnosis of cancer using imaging-based screening is likely the most important factor in lowering mortality rates for some cancers. Prediction screening, biopsy advice for detection, staging, prognosis, therapy planning, therapy guidance, therapy response, recurrence, and palliation are some of the options included under biomedical imaging.
- X-ray
- Computed tomography (CT) scan
- Ultrasound (US)
- Magnetic resonance imaging (MRI)
- Single-photon emission computed tomography (SPECT)
- Positron emission tomography (PET)
- Optical imaging
- Biomarker based detection technique
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Thomas J Webster
Northeastern University, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Rihab Melliti
Aix en Provence General Hospital, FranceSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Nanomedicine in humans: 30 years of fighting diseases
Thomas J Webster, Northeastern University, United States
Title : Diagnosis and treatment of primary cardiac lymphoma in an immunocompetent 27-year-old man
Moataz Taha Mahmoud Abdelsalam, Madinah Cardiac Center, Saudi Arabia
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational research: An option for clinical oncologists, caregivers, and consumers to realize the potential of genomics-informed care to secure human biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation